Probing the role of λ6 immunoglobulin light chain dimerization in amyloid formation
Authors:
- 1 April 2016
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1864 (4) , 409-418
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (418614)
This publication has 49 references indexed in Scilit:
- New insights into the roles of sulfated glycosaminoglycans in islet amyloid polypeptide amyloidogenesis and cytotoxicityPeptide Science, 2013
- Amyloid Formation in Light Chain AmyloidosisCurrent Topics in Medicinal Chemistry, 2013
- The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved DrugJournal of Molecular Biology, 2012
- Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascadeProceedings of the National Academy of Sciences, 2012
- Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogsBiochemical and Biophysical Research Communications, 2011
- Protein Misfolding, Functional Amyloid, and Human DiseaseAnnual Review of Biochemistry, 2006
- Therapeutic approaches to protein-misfolding diseasesNature, 2003
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Unfolding the role of protein misfolding in neurodegenerative diseasesNature Reviews Neuroscience, 2003
- Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopyProceedings of the National Academy of Sciences, 1999